Informazione:
Errore:
ID
39016
Descrizione
Along-term Study of OPC-262 in Patients With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT01634282
collegamento
https://clinicaltrials.gov/show/NCT01634282
Keywords
versioni (1)
- 20/11/19 20/11/19 -
Titolare del copyright
See clinicaltrials.gov
Caricato su
20 novembre 2019
DOI
Per favore, per richiedere un accesso.
Licenza
Creative Commons BY 4.0
Commenti del modello :
Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.
Commenti del gruppo di articoli per :
Commenti dell'articolo per :
Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.
Eligibility Diabetes, Type 2 NCT01634282
Eligibility Diabetes, Type 2 NCT01634282
- StudyEvent: Eligibility
Similar models
Eligibility Diabetes, Type 2 NCT01634282
- StudyEvent: Eligibility
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Clinical Trial Specified Completed
Item
patients who completed study 262-09-001 (namely, patients who visited the hospital at visit week 24）
boolean
C0008976 (UMLS CUI [1,1])
C0205369 (UMLS CUI [1,2])
C0205197 (UMLS CUI [1,3])
C0205369 (UMLS CUI [1,2])
C0205197 (UMLS CUI [1,3])
Informed Consent
Item
patients who are capable of giving informed consent prior to participating in this clinical study
boolean
C0021430 (UMLS CUI [1])
Contraceptive methods | Partner Contraceptive methods
Item
patients who are able to take contraceptive measures to avoid pregnancy of the patient or the patient's partner for the entire study period and for 4 weeks after the study (end of the post-observation period)
boolean
C0700589 (UMLS CUI [1])
C0682323 (UMLS CUI [2,1])
C0700589 (UMLS CUI [2,2])
C0682323 (UMLS CUI [2,1])
C0700589 (UMLS CUI [2,2])
Patients Withdrawn Clinical Trial Specified
Item
patients who withdrew from study 262-09-001
boolean
C0030705 (UMLS CUI [1,1])
C2349954 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
C0205369 (UMLS CUI [1,4])
C2349954 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
C0205369 (UMLS CUI [1,4])
Serious Adverse Event | Relationship Investigational New Drugs
Item
patients who experienced serious adverse events that the relationship with the study drug was not denied in study 262-09-001
boolean
C1519255 (UMLS CUI [1])
C0439849 (UMLS CUI [2,1])
C0013230 (UMLS CUI [2,2])
C0439849 (UMLS CUI [2,1])
C0013230 (UMLS CUI [2,2])
Serious Adverse Event | Relationship Investigational New Drugs Rejected | Symptoms Present
Item
patients who experienced serious adverse events that the relationship with the study drug are denied in study 262-09-001 and whose symptoms are still emerged at the time of initiation of this study
boolean
C1519255 (UMLS CUI [1])
C0439849 (UMLS CUI [2,1])
C0013230 (UMLS CUI [2,2])
C1548437 (UMLS CUI [2,3])
C1457887 (UMLS CUI [3,1])
C0150312 (UMLS CUI [3,2])
C0439849 (UMLS CUI [2,1])
C0013230 (UMLS CUI [2,2])
C1548437 (UMLS CUI [2,3])
C1457887 (UMLS CUI [3,1])
C0150312 (UMLS CUI [3,2])
Exclusion Criteria Fulfill Clinical Trial Specified
Item
patients who met the exclusion criteria of study 262-09-001 during the study period of study 262-09-001
boolean
C0680251 (UMLS CUI [1,1])
C1550543 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
C0205369 (UMLS CUI [1,4])
C1550543 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
C0205369 (UMLS CUI [1,4])
Pregnancy intended
Item
female patients who wish to become pregnant during the study period of study 262-09-002 or within 4 weeks after the study
boolean
C0032961 (UMLS CUI [1,1])
C1283828 (UMLS CUI [1,2])
C1283828 (UMLS CUI [1,2])
Study Subject Participation Status Inappropriate
Item
patients otherwise judged by the investigator or subinvestigator to be inappropriate for inclusion in the study
boolean
C2348568 (UMLS CUI [1,1])
C1548788 (UMLS CUI [1,2])
C1548788 (UMLS CUI [1,2])